19 terminated. 19 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 19 | Terminated 19 |
| Phase 2 | 9 | Terminated 9 |
Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. AZD7503 - Steatohepatitis | Phase 1 | Terminated | AstraZeneca | 40 | 2023-03-31 | 2025-07-20 |
| Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects ID119031166M, Placebo - Healthy Participants | Phase 1 | Terminated | IlDong Pharmaceutical Co Ltd | 67 | 2022-10-10 | 2024-07-11 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease BMS-963272, Placebo matching BMS-963272 - Nonalcoholic Fatty Liver Disease | Phase 1 | Terminated | Bristol-Myers Squibb | 9 | 2021-02-24 | 2022-06-09 |
| Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis Align Probiotic Supplement Capsule, Placebos - Fatty Liver Disease, Fibrosis, Liver | Phase 1 / Phase 2 | Terminated | Corewell Health East | 14 | 2021-01-12 | 2022-09-27 |
| TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis TD-1058, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | Terminated | Theravance Biopharma | 72 | 2020-10-15 | 2022-02-23 |
| Losartan to Improve Hip Microfracture Losartan, Placebo - Hip Osteoarthritis, Hip Impingement Syndrome | Phase 1 / Phase 2 | Terminated | Steadman Philippon Research Institute | 1 | 2020-08-07 | 2023-10-30 |
| Safety, Tolerability and Pharmacodynamics of SYNB1020 SYNB1020, Placebo - Cirrhosis | Phase 1 / Phase 2 | Terminated | Synlogic | 23 | 2018-03-19 | 2021-05-13 |
| Hypertrophic Scar Prevention by Novel Topical Gel Application Pentamidine Isethionate, Placebo - Hypertrophic Scar | Phase 1 / Phase 2 | Terminated | Mayo Clinic | 6 | 2018-03-05 | 2023-11-22 |
| Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Radiation Therapy - Cholangiocarcinoma, Cirrhosis | Phase 1 | Terminated | M.D. Anderson Cancer Center | 36 | 2016-02-15 | 2026-06-17 |
| A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis IV bolus injection of Sildenafil - Cirrhosis | Phase 1 | Terminated | University of Maryland, Baltimore | 2 | 2014-05-01 | 2022-11-15 |
| Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars Triamcinolone acetonide, Placebo - Fibrosis | Phase 1 | Terminated | GlaxoSmithKline | 9 | 2014-04-15 | 2017-05-15 |
| Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs), matched placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | Terminated | Joshua M Hare | 9 | 2013-11-13 | 2021-03-09 |
| A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures ICX-RHY-013 - Restrictive Scar Contracture, Restrictive Hypertrophic Scar | Phase 1 / Phase 2 | Terminated | University of Pittsburgh | 15 | 2011-01-01 | 2017-07-11 |
| ST266 Versus Standard Care In Treating Partial Thickness Burns ST266 - Burns | Phase 1 / Phase 2 | Terminated | Noveome Biotherapeutics, formerly Stemnion | 16 | 2009-06-01 | 2019-05-15 |
| Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells adipose tissue derived stromal cells - Liver Cirrhosis | Phase 1 | Terminated | Kanazawa University | 6 | 2009-02-01 | 2012-10-18 |
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis | Phase 1 / Phase 2 | Terminated | National Human Genome Research Institute (NHGRI) | 3 | 2007-04-01 | 2013-08-02 |
| Safety Study of Autologous Stem Cell in Liver Cirrhosis Autologous bone marrow-derived mononuclear cells infusion - Liver Cirrhosis | Phase 1 / Phase 2 | Terminated | Universidade Federal do Rio de Janeiro | 15 | 2005-11-01 | 2008-04-03 |
| Treatment of Early Systemic Sclerosis by Bosentan bosentan - Systemic Sclerosis (Scleroderma) | Phase 1 / Phase 2 | Terminated | Rikshospitalet University Hospital | 30 | 2005-01-01 | 2009-06-12 |
| Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome pentoxifylline - Hepatopulmonary Syndrome | Phase 1 | Terminated | University of Alabama at Birmingham | 9 | 2004-06-01 | 2015-03-09 |
Liver Cirrhosis (5) · Pulmonary Fibrosis (3) · Cicatrix (2) · Fatty Liver (2) · Idiopathic Pulmonary Fibrosis (2) · Non-alcoholic Fatty Liver Disease (2) · Albinism (1) · Albinism, Oculocutaneous (1) · Burns (1) · Camurati-Engelmann Syndrome (1) · Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1) · Cicatrix, Hypertrophic (1) · Hepatopulmonary Syndrome (1)
Pathologic Processes (19) · Pathological Conditions, Signs and Symptoms (19) · Digestive System Diseases (8) · Liver Diseases (8) · Respiratory Tract Diseases (4) · Lung Diseases (3) · Skin and Connective Tissue Diseases (3) · Cicatrix (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Connective Tissue Diseases (2) · Genetic Diseases, Inborn (2) · Lung Diseases, Interstitial (2) · Signs and Symptoms (2) · Skin Diseases (2)
Losartan (2) · Acetylcysteine (1) · Bosentan (1) · Erythromycin (1) · Magnetic Resonance Spectroscopy (1) · Pentamidine (1) · Pentoxifylline (1) · Pravastatin (1) · Probiotics (1) · Radiation (1) · Radiotherapy (1) · Sildenafil Citrate (1) · Triamcinolone Acetonide (1) · zileuton (1)
AstraZeneca (1) · Bristol-Myers Squibb (1) · Corewell Health East (1) · GlaxoSmithKline (1) · IlDong Pharmaceutical Co Ltd (1) · Joshua M Hare (1) · Kanazawa University (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · National Human Genome Research Institute (NHGRI) (1) · Noveome Biotherapeutics, formerly Stemnion (1) · Rikshospitalet University Hospital (1) · Steadman Philippon Research Institute (1) · Synlogic (1) · Theravance Biopharma (1)
United States (14) · United Kingdom (2) · Brazil (1) · Japan (1) · Norway (1) · Puerto Rico (1)
Alexander Meves, MD (1) · David L Steed, MD (1) · Eugene J Koay (1) · Guilherme FM Rezende, MD, PhD (1) · J. Peter Rubin, MD (1) · Jan T Gran, Professor (1) · Marc J Philippon, MD (1) · Marilyn K. Glassberg, MD (1) · Mariquit Sendelbach, DO (1) · Michael B Fallon, MD (1) · Shuichi Kaneko, M.D. (1) · Thomas Markello, M.D. (1)
PMID 18668653, PMID 26143343, PMID 38730548, PMID 41825097
P30CA016672 (1), R03DK065958 (1)